statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

This is a signal that ETON's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...

Eton Pharmaceuticals (ETON, $3.88) Stochastic Oscillator left the oversold zone on March 25, 2024

This is a signal that ETON's price could be shifting from a downtrend to an uptrend. Traders may consider buying the stock or exploring call options...

Eton Pharmaceuticals (ETON, $3.96) RSI Indicator left the oversold zone on March 22, 2024

Relief Therapeutics grants exclusive U.S. rights to Eton Pharmaceuticals for PKU GOLIKE...

Relief Therapeutics grants exclusive U.S. rights to Eton Pharmaceuticals for PKU GOLIKE

GENEVA, SWITZERLAND / ACCESSWIRE / March 22, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a biopharmaceutical company committed to delivering...

Relief Therapeutics Enters into Exclusive U.S. License and Supply Agreement with Eton Pharmaceuticals for PKU GOLIKE

PKU GOLIKE is a commercial ultra-rare disease medical formula complementary to Eton's existing metabolic franchise and specialty call pointTransaction is expected to be accretive to 2024...

Eton Pharmaceuticals Announces Acquisition of PKU GOLIKE  for Phenylketonuria

This indicator may be signaling that ETON's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...

Eton Pharmaceuticals (ETON, $4.44) entered Downtrend as Momentum indicator drops below 0 level on Mar 14, 2024

Q4 2023 Eton Pharmaceuticals Inc Earnings Call Transcript

Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript...

Eton Pharmaceuticals, Inc. (ETON) Q4 2023 Earnings Call Transcript

ETON Sees Over 100% Year-Over-Year Increase in Q4 Product Sales; Prepares for New Drug ApplicationsRelated Stocks: ETON...

Eton Pharmaceuticals Inc (ETON) Reports Robust Sales Growth and Pipeline Progress in Q4 and ...

Q4 2023 revenue of $7.3 million, representing a 109% increase from Q4 2022, marking the twelfth consecutive quarter of sequential product sales growthFull year 2023 revenues reached $31.6 million...

Eton Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results

Eton Pharmaceuticals, Inc. engages in the development, acquisition, and commercialization of prescription drug products. Its products include Biorphen, Alaway Preservative Free, zonisamide oral suspension, topiramate oral suspension, lamotrigine for oral suspension, cysteine injection, and ephedrine ready-to-use injection. The company was founded in April 2017 and is headquartered in Deer Park, IL.

Watchers	5,615
52-Wk Low	$2.42
52-Wk High	$5.81

Volume	51,664.00
52-Wk High	$5.81
52-Wk Low	$2.42

Period	Estimated	Reported	Surprise	Result
Q2'24	$0.00	--	--	N/A
Q1'24	-$0.05	-$0.03	33.33%	BEAT
Q4'23	-$0.04	-$0.09	-125.00%	MISSED
Q3'23	-$0.10	-$0.02	80.00%	BEAT
Q2'23	-$0.09	$0.18	300.00%	BEAT

ETON Eton Pharmaceuticals Inc

About

Feed

News

Sentiment

Earnings

Fundamentals